Herpes simplex virus 2 ICP0 mutant viruses are avirulent and immunogenic: implications for a genital herpes vaccine.

Herpes simplex virus 2 ICP0 mutant viruses are avirulent and immunogenic: implications for a genital herpes vaccine.
复制标题

DOI:
10.1371/journal.pone.0012251
复制
发表时间:
2010-08-17
期刊:
影响因子:
3.7
通讯作者:
Rakowski B
Rakowski B
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Halford WP;Püschel R;Rakowski B

文献摘要

参考文献

被引文献

相似文献

单纯疱疹病毒1型(HSV-1)ICP 0 −突变体对干扰素敏感,无毒力,并可引发针对HSV-1的保护性免疫(Virol J,2006,3:44)。如果单纯疱疹病毒2型(HSV-2)的ICP 0 −突变体表现出类似的特性,这种病毒可能被用于接种生殖器疱疹疫苗。目前的研究就是为了探索这种可能性。构建了几种HSV-2 ICP 0 −突变病毒,并根据三个参数进行了评价:i.干扰素敏感性; ii.小鼠中的毒力;和iii.能够引发针对HSV-2的保护性免疫。特别是一种ICP 0 −突变病毒HSV-2 0ΔNLS,在无毒力和免疫原性之间实现了最佳平衡。HSV-2 0ΔNLS对干扰素敏感。HSV-2 0ΔNLS在接种小鼠眼中复制至低水平,但被先天性Stat 1依赖性宿主免疫应答迅速抑制。HSV-2 0ΔNLS不能从接种部位传播,因此仅产生隐性感染。接种HSV-2 0ΔNLS的小鼠始终产生HSV特异性IgG抗体应答,并始终受到野生型HSV-2致死性攻毒的保护。基于它们的无毒力和免疫原性,我们认为HSV-2 ICP 0 −突变病毒值得考虑,因为它们有可能预防HSV-2和生殖器疱疹的传播。
Herpes simplex virus 1 (HSV-1) ICP0 − mutants are interferon-sensitive, avirulent, and elicit protective immunity against HSV-1 (Virol J, 2006, 3:44). If an ICP0 − mutant of herpes simplex virus 2 (HSV-2) exhibited similar properties, such a virus might be used to vaccinate against genital herpes. The current study was initiated to explore this possibility. Several HSV-2 ICP0 − mutant viruses were constructed and evaluated in terms of three parameters: i. interferon-sensitivity; ii. virulence in mice; and iii. capacity to elicit protective immunity against HSV-2. One ICP0 − mutant virus in particular, HSV-2 0ΔNLS, achieved an optimal balance between avirulence and immunogenicity. HSV-2 0ΔNLS was interferon-sensitive in cultured cells. HSV-2 0ΔNLS replicated to low levels in the eyes of inoculated mice, but was rapidly repressed by an innate, Stat 1-dependent host immune response. HSV-2 0ΔNLS failed to spread from sites of inoculation, and hence produced only inapparent infections. Mice inoculated with HSV-2 0ΔNLS consistently mounted an HSV-specific IgG antibody response, and were consistently protected against lethal challenge with wild-type HSV-2. Based on their avirulence and immunogenicity, we propose that HSV-2 ICP0 − mutant viruses merit consideration for their potential to prevent the spread of HSV-2 and genital herpes.
DOI: 10.1128/iai.35.3.1125-1132.1982
发表时间: 1982-01-01
影响因子: 3.1
作者:
CENTIFANTOFITZGERALD, YM;VARNELL, ED;KAUFMAN, HE
通讯作者: KAUFMAN, HE
DOI: 10.1128/jvi.79.2.1232-1243.2005
发表时间: 2005-01-01
影响因子: 5.4
作者:
Davido, DJ;von Zagorski, WF;Schaffer, PA
通讯作者: Schaffer, PA
DOI: 10.1016/s0264-410x(98)00470-8
发表时间: 1999-04-09
期刊: VACCINE
影响因子: 5.5
作者:
Aurelian, L;Kokuba, H;Smith, CC
通讯作者: Smith, CC
DOI: 10.1128/jvi.01063-08
发表时间: 2008-11-01
影响因子: 5.4
作者:
Boutell, Chris;Everett, Roger;Davido, David
通讯作者: Davido, David
DOI: 10.1006/viro.2001.1280
发表时间: 2002-02-15
期刊: VIROLOGY
影响因子: 3.7
作者:
Härle, P;Sainz, B;Halford, WP
通讯作者: Halford, WP